Vildagliptin and Linagliptin Inhibit NLRP3 Pyroptosis in Diabetic Lungs | ||
| Egyptian Society of Diabetes and Lipidology Journal | ||
| Volume 5, Issue 2, October 2025 PDF (927.91 K) | ||
| Document Type: Abstracts | ||
| DOI: 10.21608/esdlj.2025.456301 | ||
| Abstract | ||
| Diabetes mellitus (DM) is a multifactorial metabolic disorder characterized by hyperglycemia that induces damage across multiple organs, including the lungs. Recent evidence suggests that Nod-like receptor protein-3 (NLRP3)-mediated pyroptosis contributes significantly to diabetic complications. | ||
|
Statistics Article View: 1 |
||
